Berkeley Lights, Inc. (NasdaqGM: CELL)
Health Care · Life Sciences Tools & Services · US
$—
— today · — 1Y
Berkeley Lights, Inc. (NasdaqGM: CELL) operates in the Life Sciences Tools & Services industry within the Health Care sector.
Tweenvest scores Berkeley Lights, Inc. across four factors: quality 36/100. Its strongest factor is quality.
CELL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- —
- Revenue (TTM)
- $71.82M
- P/E
- —
- EPS
- -1.58
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $—
- 52-week low
- $—
- Avg volume (3M)
- —
- Shares outstanding
- —
- Employees
- 285
- Next earnings
- —
About Berkeley Lights, Inc.
Berkeley Lights, Inc., a digital cell biology company, focuses on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The company offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and application and workflow software. It serves in North America, the Asia Pacific, and Europe. Berkeley Lights, Inc. was incorporated in 2011 and is headquartered in Emeryville, California.
- ISIN
- US0843101017
- Founded
- 2011
- Listed since
- Jul 17, 2020
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thermo Fisher Scientific Inc.NYSE: TMO | $232.47B | $628.74 | -0.08% |
| Danaher CorporationNYSE: DHR | $151.22B | $215.11 | -1.71% |
| WuXi AppTec Co., Ltd.SHSE: 603259 | $69.06B | CN¥155.84 | -4.31% |
| Samsung Biologics Co.,Ltd.KOSE: A207940 | $51.75B | ₩1,551,000.00 | +0.19% |
| Lonza Group AGSWX: LONN | $51.21B | CHF593.40 | +0.95% |
| Agilent Technologies, Inc.NYSE: A | $43.33B | $153.43 | -3.50% |
| IQVIA Holdings Inc.NYSE: IQV | $42.84B | $260.24 | +0.16% |
| Waters CorporationNYSE: WAT | $40.36B | $410.75 | +0.01% |
Figures last refreshed Aug 18, 2026.